Non-invasive prenatal diagnosis (NIPD): current and emerging technologies
2023

Non-invasive prenatal diagnosis: current and emerging technologies

Sample size: 1949 publication Evidence: high

Author Information

Author(s): Hanson Britt, Paternoster Ben, Povarnitsyn Nikita, Scotchman Elizabeth, Chitty Lyn, Chandler Natalie

Primary Institution: North Thames Genomic Laboratory Hub, Great Ormond Street NHS Foundation Trust

Conclusion

Non-invasive prenatal diagnosis (NIPD) has significantly advanced the field of prenatal testing by reducing the need for invasive procedures and expanding the range of detectable genetic conditions.

Supporting Evidence

  • NIPD has been in clinical service in England since 2012.
  • Fetal-derived genomic material is present in a highly fragmented form in maternal blood.
  • NIPD has revolutionized prenatal diagnostics by reducing invasive sampling procedures.

Takeaway

Doctors can now check if a baby has certain genetic conditions without needing to do risky procedures, thanks to new blood tests that look for tiny bits of baby DNA in the mom's blood.

Methodology

This review discusses various technologies for non-invasive prenatal diagnosis, including the analysis of cell-free fetal DNA in maternal blood.

Limitations

The review highlights challenges in detecting maternally inherited variants due to the high background of maternal DNA.

Participant Demographics

The study references a cohort of 1,949 low- and high-risk singleton pregnancies.

Digital Object Identifier (DOI)

10.20517/evcna.2022.44

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication